118 related articles for article (PubMed ID: 37137852)
1. [Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].
He N; Feng G; Zhang FN; Hao S; Li R; Zhao ZQ; Tian YW; Yan HL
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):265-270. PubMed ID: 37137852
[No Abstract] [Full Text] [Related]
2. Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis.
He N; Feng G; Zhang C; Wu F; Zhang T; Yang Y
Mol Med Rep; 2020 Oct; 22(4):2705-2714. PubMed ID: 32945374
[TBL] [Abstract][Full Text] [Related]
3.
Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
Hu J; Hu B; Gui YC; Tan ZB; Xu JW
Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
[TBL] [Abstract][Full Text] [Related]
5. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
[TBL] [Abstract][Full Text] [Related]
6. Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma.
Bannaga AS; Alvarez R; Zhou L; Petchey M; Noufaily A; Hitchins MP; Arasaradnam RP
HPB (Oxford); 2021 Oct; 23(10):1595-1606. PubMed ID: 33931320
[TBL] [Abstract][Full Text] [Related]
7. Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population.
Zheng K; Dai L; Zhao Y; Li L; Li W; Zhang X; Su Q; Wu R; Jiang Y; Chen Y; Ran J
BMC Gastroenterol; 2023 Jul; 23(1):260. PubMed ID: 37525116
[TBL] [Abstract][Full Text] [Related]
8. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
[TBL] [Abstract][Full Text] [Related]
10. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract][Full Text] [Related]
11. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
12. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
[TBL] [Abstract][Full Text] [Related]
13. [Value of plasma SEPTIN9 methylation detection for diagnosis and predicting radiosensitivity of esophageal carcinoma].
Sun Q; Liu J; Fan X; Zhou Y; Wang X; Cui Z
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1214-1219. PubMed ID: 34549713
[TBL] [Abstract][Full Text] [Related]
14. Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma.
Huang F; Yang G; Jiang H; Chen X; Yang Y; Yu Q; Pan B; Wang B; Guo W; Yang W; Zhang C
Technol Cancer Res Treat; 2022; 21():15330338221144510. PubMed ID: 36573042
[No Abstract] [Full Text] [Related]
15. mSEPT9 Can Monitor the Response and Predict the Prognosis of Stage IV Colorectal Cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
Liu W; Hu P; Liu J; Chen L
J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
[TBL] [Abstract][Full Text] [Related]
16. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract][Full Text] [Related]
17. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
[TBL] [Abstract][Full Text] [Related]
18. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.
Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y
Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784
[TBL] [Abstract][Full Text] [Related]
19. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
[TBL] [Abstract][Full Text] [Related]
20. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
